IDO antagonist-1, identified by its CAS number 2206797-88-6, is a chemical compound that functions as an inhibitor of indoleamine 2,3-dioxygenase (IDO), an enzyme involved in the catabolism of tryptophan. This inhibition is significant in the context of immunology and cancer therapy, as IDO plays a role in immune tolerance and tumor immune evasion. The compound is characterized by its ability to modulate immune responses, potentially enhancing the efficacy of immunotherapies. IDO antagonist-1 is typically studied for its pharmacological properties, including its selectivity, potency, and mechanism of action. Additionally, its solubility, stability, and bioavailability are important factors that influence its therapeutic potential. Research into IDO antagonists like this compound is ongoing, with a focus on their application in treating various cancers and autoimmune diseases by restoring immune function. As with many experimental compounds, detailed safety and efficacy profiles are essential for clinical development.

IDO antagonist-1

2206797-88-6: IDO antagonist-1, identified by its CAS number 2206797-88-6, is a chemical compound that functions as an inhibitor of indoleamine 2,3-dioxygenase (IDO), an enzyme involved in the catabolism of tryptophan. This inhibition is significant in the context of immunology and cancer therapy, as IDO plays a role in immune tolerance and tumor immune evasion. The compound is characterized by its ability to modulate immune responses, potentially enhancing the efficacy of immunotherapies. IDO antagonist-1 is typically studied for its pharmacological properties, including its selectivity, potency, and mechanism of action. Additionally, its solubility, stability, and bioavailability are important factors that influence its therapeutic potential. Research into IDO antagonists like this compound is ongoing, with a focus on their application in treating various cancers and autoimmune diseases by restoring immune function. As with many experimental compounds, detailed safety and efficacy profiles are essential for clinical development.

<p>IDO antagonist-1 (compound 163), an IDO antagonist, effectively inhibits the growth of pancreatic adenocarcinoma cells in C57BL/6 mice [1].</p>

CAS 2206797-88-6

IDO antagonist-1

IDO antagonist-1

Ref: TM-T86703